A Real-World Prognosis in Idiopathic Pulmonary Fibrosis: A Special Reference to the Role of Antifibrotic Agents for the Elderly

• Published in: Journal of clinical medicine Vol. 12; no. 10; p. 3564
• Main Authors: Honda, Kojiro, Saraya, Takeshi, Ishii, Haruyuki
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 19.05.2023; MDPI
• Subjects: Age; Aged patients; Body mass index; Classification; Clinical medicine; Demographic aspects; Drug dosages; Drug therapy; Females; Medical prognosis; Patients; Prognosis; Pulmonary fibrosis; Regression analysis; Japan; long-term treatment; acute exacerbation; antifibrotic agents; elderly patients; IPF; survival probability

Background: Idiopathic pulmonary fibrosis (IPF) is the most common and severe form of idiopathic interstitial pneumonia, and its prevalence increases with age. In the era of pre-antifibrotic agents, the median survival time of Japanese patients with IPF is 35 months, with a 5-year survival rate in w...